Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Picard Medical (PMI) Change in Cash (2024 - 2026)

Picard Medical posted quarterly Change in Cash of -$11.3 million for Q1 2026, down 2013.85% year-on-year from $592000.0 in Q1 2025, and down 231.16% on a QoQ basis from $8.6 million in Q4 2025.

Picard Medical (PMI) has 3 years of Change in Cash data on file, last reported at -$11.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Cash fell 2013.85% year-over-year to -$11.3 million; the trailing twelve-month figure through Mar 2026 stood at -$567000.0 (changed N/A YoY), and the FY2025 full-year result was $11.4 million, up 7772.3% from the prior year.
  • Change in Cash for Q1 2026 stood at -$11.3 million, down from $8.6 million in the prior quarter.
  • Across five years, Change in Cash topped out at $8.6 million in Q4 2025 and bottomed at -$11.3 million in Q1 2026.
  • The 3-year median for Change in Cash is $90000.0 (2024), against an average of $6142.9.
  • The widest annual swing landed in 2025, when Change in Cash jumped 9497.78%; it then tumbled 2013.85% in 2026.
  • A 3-year view of Change in Cash shows it stood at $90000.0 in 2024, then surged by 9497.78% to $8.6 million in 2025, then plunged by 231.16% to -$11.3 million in 2026.
  • The last three Change in Cash figures came in at -$11.3 million (Q1 2026), $8.6 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -1.72 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -1.13 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -136.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -504.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -492.00 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -2.23 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.90 Mn
10 Picard Medical 12.10 Mn 12.10 Mn 275,000.00 -11.33 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -11.33 Mn
Dec 31, 2025 8.64 Mn
Sep 30, 2025 2.40 Mn
Dec 31, 2024 90,000.00
Sep 30, 2024 -72,000.00